Answers are grounded in this paper and cite their sources.
Abstract The present sensing platform cannot meet the needs of monitoring uric acid because of poor self-powered capacity, operational stability and detection sensitivity. The paper reports synthesis of cobalt nanocrystal-graphene quantum dot-Ti₃C₂TX monolithic film electrode (Co-GQD-Ti₃C₂TX) via self-assembly of Ti₃C₂TX nanosheets induced by protonated arginine-functionalized graphene quantum dot and subsequent reduction of cobalt (III). The resulting Co-GQD-Ti₃C₂TX shows good monolithic architecture, mechanical property, dispersibility and conductivity. The structure achieves excellent supercapacitor and sensing behavior. The self-charging supercapacitor produced by printing viscous Co-GQD-Ti₃C₂TX hydrogel on back of flexible solar cell provides high specific capacitance (296 F g⁻¹ at 1 A g⁻¹), high-rate capacity (153 F g⁻¹ at 20 A g⁻¹), capacity retention (98.1% over 10000-cycle) and energy density (29.6 Wh kg⁻¹ at 299.9 W kg⁻¹). The electrochemical chip produced by printing Co-GQD-Ti₃C₂TX hydrogel on paper exhibits sensitive electrochemical response towards uric acid. The increase of uric acid between 0.01 and 800 µM causes a linear increase in differential pulse voltammetry signal with detection limit of 0.0032 µM. The self-powered sensing platform integrating self-charging supercapacitor, electrochemical chip and micro electrochemical workstation was contentedly applied in monitoring uric acid in sweats and shows one broad application prospect in wearable electronic health monitoring device.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: